Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
News|Videos|July 1, 2024
Learn about the MyFreeStyle program
Advertisement
Advertisement
Related to this article
In a review of records assessing patients with type 2 diabetes, researchers provide a comprehensive detail of strategies leading to diabetes remission though gaps persist.
Exploring the effects of weight-loss and GLP-1 therapies, researchers determine the specific metabolic determinants that lead to patients’ weight reduction.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Advertisement
Advertisement
Trending on Drug Topics
1
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
2
Study Finds Reduced Cardiovascular Risk With Hormone Therapy Initiation
3
FDA Approves Onswik Weekly Insulin for Adults With T2D
4
Conflicting Measles Reports Perpetuate as Cases Continue to Rise
5